Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients

Table 1 Characteristics of the study population

Features	mean ± SD	Minimum	Maximum
Gender (male/female)	91/23
HBV DNA (copies/mL)
(< 1000/≥ 1000)	44/70
(< 103/103-105/≥ 105)	44/32/38
E antigen (+/-)	52/62
Age (yr)	38.32 ± 11.36	15	67
PLT( × 109/L)	174.44 ± 62.68	50.6	334
T.Bil (g/dL)	0.88 ± 0.49	0.27	3.14
D.Bil (g/dL)	0.29 ± 0.23	0.08	1.39
ALT (IU/L)	69.32 ± 116.40	10.00	983
AST (IU/L)	48.60 ± 64.56	13	594
ALB (g/dL)	4.15 ± 0.43	2.85	5.26
GLOB (g/dL)	2.98 ± 0.52	1.75	4.47
ALP (IU/L)	80.10 ± 27.38	24	154
GGT (IU/L)	59.46 ± 66.92	5	430
PT (s)	12.01 ± 1.58	9.3	18.1

HBV: Hepatitis B virus; GLOB: Globulin; PLT: Platelet count; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; T.bil: Total bilirubin; D.bil: Direct bilirubin; ALB: Albumin; GGT: Glutamyltransferase; ALP: Alkaline phosphatase; PT: Prothrombin time.